Business

Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer

Financial Post · August 21, 2026 at 7:33 a.m.

WARMINSTER, Pa., Aug.

21, 2026 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced plans

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer

More from Financial Post

Global Data Center Investment Projected to Reach $3 Trillion By 2030

NetworkNews Audio Announces Audio Press Release (APR) Discussing Deployment-First Structure Where Competitive Advantage Sits in Robotic Space

Carney bets Canada can live with tariffs to unlock investment

MAX Power Shareholders Approve Sprott Control Person Resolution

More in Business

Global Data Center Investment Projected to Reach $3 Trillion By 2030

NetworkNews Audio Announces Audio Press Release (APR) Discussing Deployment-First Structure Where Competitive Advantage Sits in Robotic Space

Carney bets Canada can live with tariffs to unlock investment

MAX Power Shareholders Approve Sprott Control Person Resolution

Posthaste: Parents hit roadblocks in education savings

Aluminum premium slips as U.S. set to cut tariffs on Canada metal